285 related articles for article (PubMed ID: 11455617)
21. Microglia cyclooxygenase-2 activity in experimental gliomas: possible role in cerebral edema formation.
Badie B; Schartner JM; Hagar AR; Prabakaran S; Peebles TR; Bartley B; Lapsiwala S; Resnick DK; Vorpahl J
Clin Cancer Res; 2003 Feb; 9(2):872-7. PubMed ID: 12576462
[TBL] [Abstract][Full Text] [Related]
22. Novel therapies for malignant gliomas: a local affair?
Rainov NG; Söling A; Heidecke V
Neurosurg Focus; 2006 Apr; 20(4):E9. PubMed ID: 16709040
[TBL] [Abstract][Full Text] [Related]
23. IL-1beta, an immediate early protein secreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK and NF-kappaB pathways.
Kim YJ; Hwang SY; Oh ES; Oh S; Han IO
J Neurosci Res; 2006 Oct; 84(5):1037-46. PubMed ID: 16881054
[TBL] [Abstract][Full Text] [Related]
24. Differentiation of primary adult microglia alters their response to TLR8-mediated activation but not their capacity as APC.
Zuiderwijk-Sick EA; van der Putten C; Bsibsi M; Deuzing IP; de Boer W; Persoon-Deen C; Kondova I; Boven LA; van Noort JM; 't Hart BA; Amor S; Bajramovic JJ
Glia; 2007 Nov; 55(15):1589-600. PubMed ID: 17823968
[TBL] [Abstract][Full Text] [Related]
25. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor.
Wesolowska A; Kwiatkowska A; Slomnicki L; Dembinski M; Master A; Sliwa M; Franciszkiewicz K; Chouaib S; Kaminska B
Oncogene; 2008 Feb; 27(7):918-30. PubMed ID: 17684491
[TBL] [Abstract][Full Text] [Related]
26. Microglia in normal condition and pathology.
Pivneva TA
Fiziol Zh (1994); 2008; 54(5):81-9. PubMed ID: 19058517
[TBL] [Abstract][Full Text] [Related]
27. [Microglia--biology and relevance to disease].
Wirenfeldt M; Ladeby R; Dalmau I; Banati RB; Finsen B
Ugeskr Laeger; 2005 Aug; 167(33):3025-30. PubMed ID: 16109243
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
[TBL] [Abstract][Full Text] [Related]
29. Response of microglial cells to experimental rat glioma.
Morioka T; Baba T; Black KL; Streit WJ
Glia; 1992; 6(1):75-9. PubMed ID: 1387388
[TBL] [Abstract][Full Text] [Related]
30. Fos-related antigen 1 modulates malignant features of glioma cells.
Debinski W; Gibo DM
Mol Cancer Res; 2005 Apr; 3(4):237-49. PubMed ID: 15831677
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of local immunoresistance in glioma.
Albesiano E; Han JE; Lim M
Neurosurg Clin N Am; 2010 Jan; 21(1):17-29. PubMed ID: 19944963
[TBL] [Abstract][Full Text] [Related]
32. Microglia and multiple sclerosis.
Jack C; Ruffini F; Bar-Or A; Antel JP
J Neurosci Res; 2005 Aug; 81(3):363-73. PubMed ID: 15948188
[TBL] [Abstract][Full Text] [Related]
33. Immunoregulation of microglial functional properties.
Cross AK; Woodroofe MN
Microsc Res Tech; 2001 Jul; 54(1):10-7. PubMed ID: 11526951
[TBL] [Abstract][Full Text] [Related]
34. Characterization of microglia/macrophages in gliomas developed in S-100β-v-erbB transgenic rats.
Sasaki A; Yokoo H; Tanaka Y; Homma T; Nakazato Y; Ohgaki H
Neuropathology; 2013 Oct; 33(5):505-14. PubMed ID: 23331472
[TBL] [Abstract][Full Text] [Related]
35. Sheep erythrocyte demonstrated better effect than IL-2 and IFN-gamma as biological response modifier against glioma in experimental model.
Sarkar S; Ghosh A; Dutta S; Roy RU; Begum Z; Mukherjee J; Chaudhuri S; Chaudhuri S
Indian J Exp Biol; 2005 May; 43(5):414-9. PubMed ID: 15900905
[TBL] [Abstract][Full Text] [Related]
36. Dendritic cell-based immunotherapy for malignant gliomas.
Akasaki Y; Black KL; Yu JS
Expert Rev Neurother; 2005 Jul; 5(4):497-508. PubMed ID: 16026233
[TBL] [Abstract][Full Text] [Related]
37. Platelet-derived growth factor-mediated gliomagenesis and brain tumor recruitment.
Fomchenko EI; Holland EC
Neurosurg Clin N Am; 2007 Jan; 18(1):39-58, viii. PubMed ID: 17244553
[TBL] [Abstract][Full Text] [Related]
38. Site-specific anti-tumor immunity: differences in DC function, TGF-beta production and numbers of intratumoral Foxp3+ Treg.
Biollaz G; Bernasconi L; Cretton C; Püntener U; Frei K; Fontana A; Suter T
Eur J Immunol; 2009 May; 39(5):1323-33. PubMed ID: 19337997
[TBL] [Abstract][Full Text] [Related]
39. Survivin expression and its relation with proliferation, apoptosis, and angiogenesis in brain gliomas.
Zhen HN; Zhang X; Hu PZ; Yang TT; Fei Z; Zhang JN; Fu LA; He XS; Ma FC; Wang XL
Cancer; 2005 Dec; 104(12):2775-83. PubMed ID: 16284993
[TBL] [Abstract][Full Text] [Related]
40. Integrins: molecular determinants of glioma invasion.
D'Abaco GM; Kaye AH
J Clin Neurosci; 2007 Nov; 14(11):1041-8. PubMed ID: 17954373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
